Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (18930)	4/10/1998 12:36:00 PM
From: Hippieslayer	Respond to of 32384

BOb, part of that move was based on one day. The day that the targretin animal study on breast cancer came out. IMO, that was much ado about nothing. Granted it was significant in rats, but I don't see many people wearing ribbons for rat breast cancer or walking from LA to SF to for rats with breast cancer. I'm more eager to see the same results with human females. And I'm willing to bet that if we see the same results in human females, lgnd will more than double in a day.